Mistaken identity
- 1 November 2003
- journal article
- Published by Wolters Kluwer Health in European Journal of Gastroenterology & Hepatology
- Vol. 15 (11) , 1245-1247
- https://doi.org/10.1097/00042737-200311000-00016
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Rational dosing of azathioprine and 6-mercaptopurineGut, 2001
- Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's diseaseGastroenterology, 1999
- Thiopurine methyltransferase levels should be measured before commening patients on azathioprineBritish Journal of Dermatology, 1997
- Recombinant Erythropoietin for the Treatment of Anemia in Inflammatory Bowel DiseaseNew England Journal of Medicine, 1996
- Congenital thiopurine methyltransferase deficiency and 6-mercaptopurine toxicity during treatment for acute lymphoblastic leukaemia.Archives of Disease in Childhood, 1993
- Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience.Gut, 1993
- The clinical pharmacology of 6-mercaptopurineEuropean Journal of Clinical Pharmacology, 1992
- THE IMPORTANCE OF THIOPURINE METHYLTRANSFERASE ACTIVITY FOR THE USE OF AZATHIOPRINE IN TRANSPLANT RECIPIENTS1Transplantation, 1992
- Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemiaThe Lancet, 1990
- Remediable Defects in Crohn DiseaseArchives of internal medicine (1960), 1975